Preventive Effect of Dihydromyricetin against Cisplatin-Induced Nephrotoxicity In Vitro and In Vivo

Table 2

Effect of Dihydromyricetin on oxidative stress in different experimental groups.

Groups	MDA (μM/g tissue)	SOD (U/mg protein)	CAT (U/mg protein)
Normal
DMY 500
Cis
Cis+DMY 500

Cis: cisplatin; DMY 500: DMY 500 mg/kg; Cis+DMY 500: cisplatin+DMY 500 mg/kg. Data is expressed as mean ± SD of 4 mice per group. MDA: malondialdehyde, SOD: superoxide dismutase, CAT: catalase activity. versus normal group. versus cisplatin treatment group. versus cisplatin treatment group.